Search

Ocugen Inc

Abierto

1.03 4.04

Resumen

Variación precio

24h

Actual

Mínimo

0.98

Máximo

1.08

Métricas clave

By Trading Economics

Ingresos

-5.7M

-25M

Ventas

-45K

1.5M

BPA

-0.07

Margen de beneficios

-1,671.841

Empleados

116

EBITDA

-2.5M

-20M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+912.5% upside

Dividendos

By Acuity

Próximas Ganancias

4 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-67M

349M

Apertura anterior

-3.01

Cierre anterior

1.03

Ocugen Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 sept 2026, 23:56 UTC

News

EUR/GBP rises as Germany's business expectations for September exceed forecasts, reaching 90.4 and indicating notable strength in today's performance.

24 sept 2026, 23:56 UTC

RealReal Inc is trading modestly lower in after-market hours, having retraced from an initial gain and remaining near the lower end of its one-month range.

24 sept 2026, 23:56 UTC

Correlated Moves

Carlyle Group Inc is higher in after-market trading, likely moving in sympathy with Brookfield Asset Management amid mixed economic signals.

24 sept 2026, 23:56 UTC

Correlated Moves

Targa Resources Corp is trading modestly higher in after-market hours, potentially influenced by Permian Resources Corp's significant recovery from earlier lows.

24 sept 2026, 23:56 UTC

Correlated Moves

Jack Henry & Associates Inc traded modestly higher in after-market hours, continuing a stable trend since Thursday's close, influenced by Fidelity National Information Services Inc.

24 sept 2026, 23:56 UTC

Baxter International Inc is trading slightly higher in after-market hours, recovering from an earlier decline but remains below its 20-day moving average.

24 sept 2026, 23:56 UTC

Correlated Moves

Matador Resources Co is trading lower in after-market hours, reflecting a decline in oil prices and positioned near the lower end of its one-month range.

24 sept 2026, 23:56 UTC

Correlated Moves

EMCOR Group Inc is trading lower in after-market hours, continuing a decline over the past four sessions amid broader losses in the Defiance Quantum ETF.

24 sept 2026, 23:56 UTC

LKQ Corp saw a modest increase in after-market trading, settling with a cumulative return around 0.25% since Thursday's close, but remains below its 20-day moving average.

24 sept 2026, 23:55 UTC

Globalstar Inc is seeing a modest decline in after-market trading, settling near the lower end of its one-month trading range.

24 sept 2026, 23:55 UTC

Advanced in after-market trading, supported by strong performance.

24 sept 2026, 23:55 UTC

News

LPL Financial reported total client assets of $2.60 trillion for August 2026, with the stock trading modestly lower in after-market hours.

24 sept 2026, 23:55 UTC

Event

CarMax Inc shares have moved modestly lower in after-market trading ahead of its Q2 FY2027 earnings report, with EPS expected at $0.70.

24 sept 2026, 23:55 UTC

Roivant Sciences Ltd is seeing a slight uptick in after-market hours, despite remaining roughly flat since Thursday's close and below its 20-day moving average.

24 sept 2026, 23:55 UTC

CoreCivic Inc is trading lower in after-market hours, continuing a decline since Thursday's close and reflecting notable weakness at the low end of its range.

24 sept 2026, 23:55 UTC

Lamb Weston Holdings Inc is trading modestly higher in after-market hours, marking its highest cumulative return since Thursday's close despite recent volatility.

24 sept 2026, 23:55 UTC

Hershey Co's shares are trading modestly higher in after-market hours, despite remaining below their 20-day moving average and near the lower end of their one-month range.

24 sept 2026, 23:55 UTC

Ascendis Pharma A/S is trading modestly lower in after-market hours, significantly below its 20-day moving average and near the lower end of its one-month trading range.

24 sept 2026, 23:55 UTC

Alpha Metallurgical Resources Inc traded modestly higher in after-market hours, though it remains significantly below its 20-day moving average.

24 sept 2026, 23:55 UTC

Bank OZK traded modestly higher in after-market hours on Thursday, despite a decline from an earlier high and being below its 20-day moving average.

24 sept 2026, 23:55 UTC

Crocs Inc. is trading slightly lower in after-market hours, remaining roughly flat since Thursday's close after briefly peaking nearly 1% above the previous close.

24 sept 2026, 23:55 UTC

Franklin Resources Inc is trading modestly lower in after-market hours, marking a fifth consecutive session of declines and remaining below its 20-day moving average.

24 sept 2026, 23:55 UTC

News
Social Media

MGM Resorts International shares are modestly lower in after-market trading as it considers a bid for People Incorporated amid uncertain negotiations.

24 sept 2026, 23:52 UTC

Mexican Business Confidence Remains Cautious Ahead of September Survey, Stuck Below Neutral Threshold Amid Inflation Concerns.

24 sept 2026, 23:52 UTC

UK Consumer Confidence Index Surprises with -13.0, Indicating Resilience Amid Inflationary Pressures

24 sept 2026, 23:52 UTC

Upcoming ADP Employment Change report on September 30 raises concerns over declining job growth amid rising bond yields and inflation risks.

24 sept 2026, 23:52 UTC

Michigan Consumer Sentiment Index for September 2026 Forecasted at 47.6 Amid Ongoing Economic Concerns and Inflationary Pressures

24 sept 2026, 23:51 UTC

Wolfspeed Inc's shares are declining in after-market hours, reflecting broader market weakness amid rising U.S. Treasury yields and inflation concerns.

24 sept 2026, 23:51 UTC

Correlated Moves

United Bankshares Inc is trading modestly higher in after-market hours, following gains linked to the Vanguard Morningstar Value ETF and strong performances from key holdings.

24 sept 2026, 23:51 UTC

ProPetro Holding Corp is trading higher in after-market hours, showing notable upward movement despite remaining significantly below its 20-day moving average.

Comparación entre iguales

Cambio de precio

Ocugen Inc previsión

Precio Objetivo

By TipRanks

912.5% repunte

Estimación a 12 Meses

Media 10.125 USD  912.5%

Máximo 12 USD

Mínimo 8 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ocugen Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

4

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.